Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

Wroclaw Medical University is the lead sponsor of 30 current clinical trials in our Poland register. 13 are recruiting patients now. The most common phase is Observational. The drugs named most often in its trials are Influenza vaccination, Ferinject and IPRF. The most-studied condition is Atrial Fibrillation (AF).

ClinicalTrials.gov trials by status

Recruiting1343%
Not yet open413%
Active, closed413%
By invitation930%

Trials by phase

Observational1653%
Not applicable827%
Phase 4413%
Phase 2/327%

Clinical trials sponsored by Wroclaw Medical University

30 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Polish Nationwide Registry of Diagnostics, Treatment and Outcome in Patients With Cardiogenic Shock NCT06697093 · ClinicalTrials.gov ↗ · Cardiogenic Shock	Observational	Recruiting	2025-04	Poland
Simple Urine Composition-based Personalized Algorithm for Effective Congestion Relief in Decompensated Heart Failure NCT07099885 · ClinicalTrials.gov ↗ · Acute Heart Failure (AHF), Congestion, Venous	Not applicable	Recruiting	2025-08	Poland
Evaluation of the Factors Associated With BRADYcardia Following Pulmonary Vein Isolation Using Pulsed Field Ablation NCT07809347 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Pulsed Field Ablation, Bradycardia	Observational	Recruiting	2026-01	Poland
Effect of INtravenous FERRic Carboxymaltose Onmortality and Cardiovascular Morbidity, and Quality of Life in Iron Deficient Patients With Recent Myocardial infarCTion NCT05759078 · ClinicalTrials.gov ↗ · Myocardial Infarction, Acute Drugs: Ferinject, Sodium Chloride Inj	Phase 4	Recruiting	2022-09	Poland
Pre-discharge Influenza Vaccination in Patients Hospitalized for Acute Cardiac Conditions NCT07617376 · ClinicalTrials.gov ↗ · Myocardial Infarction, Decompensated Chronic Heart Failure, Acute Heart Failure (AHF) Drug: Influenza vaccination	Phase 4	Recruiting	2025-11	Poland
Wroclaw Out-Of-Hospital Cardiac Arrest Registry NCT05132387 · ClinicalTrials.gov ↗ · Out-Of-Hospital Cardiac Arrest	Observational	Recruiting	2021-10	Poland
Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors NCT07157475 · ClinicalTrials.gov ↗ · Peripheral Arterial Disease(PAD)	Observational	Recruiting	2025-07	Poland
Registry of Atrial Arrhythmia Ablation Procedures Using Pulsed Field Ablation in Poland NCT07109141 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Atrial Flutter, Atrial Tachycardia	Observational	Recruiting	2024-08	Poland
Evaluation of the Efficacy of Allergen-specific Immunotherapy Using Assessment in an Allergen Exposure chamber-a Randomized Placebo-controlled Double-blind Study NCT06778213 · ClinicalTrials.gov ↗ · Allergic Rhinoconjunctivitis	Phase 4	Recruiting	2024-11	Poland
Electroporation vs. Radiofrequency Ablation Guided by 3D Imaging in Repeat Procedures for Atrial Fibrillation NCT07141745 · ClinicalTrials.gov ↗ · Atrial Fibrillation (AF), Ablation Techniques, Radiofrequency Catheter Ablation	Not applicable	Recruiting	2025-08	Poland
Immunological-Clinical Evaluation of the Etiopathogenesis of Peri-Implantitis NCT07012915 · ClinicalTrials.gov ↗ · Peri-Implantitis	Not applicable	Recruiting	2025-07	Poland
Comparison of Three Types of Distal Arteriovenous Fistulas: SBAVF, RCAVF, and RCAVF With Venous Branch Patch. NCT06550479 · ClinicalTrials.gov ↗ · Dialysis; Complications, Vascular Access Complication	Not applicable	Recruiting	2024-01	Poland
Lower Silesia Cardiogenic Shock Initiative NCT05465200 · ClinicalTrials.gov ↗ · Cardiogenic Shock	Observational	Recruiting	2022-01	Poland
Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to Hospitalized Patients NCT07159932 · ClinicalTrials.gov ↗ · Acute Admitted Multimorbid Patients	Not applicable	Not yet open	2026-01	Poland
Bruxism Induced by Obstructive Sleep Apnoea. NCT07511946 · ClinicalTrials.gov ↗ · Sleep Apnea Syndrome, Obstructive, Bruxism, Sleep-Related, Upper Respiratory Tract Illness	Observational	Not yet open	2026-09	Poland
Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers NCT07413419 · ClinicalTrials.gov ↗ · Heart Failure (HF), Self Care, Caregiver	Not applicable	Not yet open	2026-02	Poland
Effects of Repletion of Sodium Chloride on Natriuresis, Blood Pressure, and Neurohormonal Activity in Patients With Chronic Heart Failure With Reduced Ejection Fraction NCT07614295 · ClinicalTrials.gov ↗ · Chronic Heart Failure With Reduced Ejection Fraction	Not applicable	Not yet open	2026-05	Poland
Pain, Central Sensitization and Psychoemotional State in Patients With Chronic Masticatory Muscle Pain NCT05676827 · ClinicalTrials.gov ↗ · TMD, Masticatory Muscle Pain	Observational	By invitation	2023-09	Poland
Relationship Between Selected Parameters and Bruxism NCT04214561 · ClinicalTrials.gov ↗ · Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder	Observational	By invitation	2019-12	Poland
Selected Disorders and Sleep Bruxism NCT03083405 · ClinicalTrials.gov ↗ · Sleep Bruxism, Hypertension, Thyroid Dysfunction	Observational	By invitation	2017-04	Poland
Determination of Chronic Pain, Anxiety, Depression and Perceived Stress in Adults With Temporomandibular Disorders NCT05183503 · ClinicalTrials.gov ↗ · Temporomandibular Disorder, Depression, Anxiety	Observational	By invitation	2018-11	Poland
Concentration of Receptors With Affinity for Cannabidiol and Cannabinol and the Effect on Chronic Orofacial Pain of Muscle Origin NCT06405646 · ClinicalTrials.gov ↗ · Myalgia, Muscle Pain, Orofacial Pain	Observational	By invitation	2025-04	Poland
Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry NCT07511959 · ClinicalTrials.gov ↗ · Temporomandibular Disorders (TMD), Muscle Pain, TMJ Pain	Observational	By invitation	2026-05	Poland
The Effectiveness of CBD and CBN in the Treatment of Facial Pain and Headache of Muscular Origin NCT05961501 · ClinicalTrials.gov ↗ · Myalgia, Muscle Pain, Orofacial Pain	Phase 2/3	By invitation	2025-04	Poland
Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management NCT05214924 · ClinicalTrials.gov ↗ · Temporomandibular Disorder, Temporomandibular Joint Disorders, Temporomandibular Arthritis Drugs: IPRF, Platelet-Rich Fibrin, Platelet rich plasma	Phase 2/3	By invitation	2022-01	Poland
The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders. NCT05890911 · ClinicalTrials.gov ↗ · Sleep Apnea, Sleep-Disordered Breathing	Observational	By invitation	2023-06	Poland
Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea NCT03928665 · ClinicalTrials.gov ↗ · Sleep Apnea, Glaucoma, Ocular Hypertension	Observational	Active, closed	2012-10	Poland
Vaccination Against Influenza Pre-discharge in Heart Failure NCT06725927 · ClinicalTrials.gov ↗ · Heart Failure Drug: Influenza vaccination	Phase 4	Active, closed	2024-12	Poland
The Impact of Expandable Cryoballoon on Autonomic Control of the Heart NCT06053606 · ClinicalTrials.gov ↗ · Paroxysmal Atrial Fibrillation	Not applicable	Active, closed	2024-05	Poland
A Multifaceted Assessment of Eating Behaviors, Anthropometric Measurements and Body Composition in Pediatric Patients With Drug-resistant Epilepsy on a Ketogenic Diet and Healthy Children NCT07714226 · ClinicalTrials.gov ↗ · Epilepsy Intractable	Observational	Active, closed	2023-04	Poland

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in Wroclaw Medical University trials

6 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Influenza vaccination2 Ferinject1 IPRF1 Platelet rich plasma1 Platelet-Rich Fibrin1 Sodium Chloride Inj1

Conditions in Wroclaw Medical University trials

57 conditions

Atrial Fibrillation (AF)3Muscle Pain3Sleep Apnea2Cardiogenic Shock2Acute Heart Failure (AHF)2Sleep Bruxism2Pain2Pulsed Field Ablation2Temporomandibular Disorder2Myalgia2Orofacial Pain2Headache, Tension2Ablation Techniques2Glaucoma1Ocular Hypertension1Acute Admitted Multimorbid Patients1Heart Failure1TMD1Masticatory Muscle Pain1Sleep Apnea Syndrome, Obstructive1Bruxism, Sleep-Related1Upper Respiratory Tract Illness1Congestion, Venous1Sleep Disorder1

By trial register

Register	Trials	Recruiting
Clinical trials in Poland	30	13

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Atrial Fibrillation (AF)

Sponsor	Trials
Beijing Anzhen Hospital	13
Shanghai Chest Hospital	6
Samsung Medical Center	5
Charles University, Czech Republic	4
Ewha Womans University Mokdong Hospital	4
Second Affiliated Hospital of Nanchang University	2
Jiangsu Taizhou People's Hospital	2
Hangzhou Dinova EP Technology	2
Asklepios proresearch	2
Herlev and Gentofte Hospital	2

Sponsors with the most current trials registered for this condition.

Questions about Wroclaw Medical University trials

How many clinical trials does Wroclaw Medical University sponsor?

Wroclaw Medical University is the lead sponsor of 30 current trials on ClinicalTrials.gov in our Poland register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Wroclaw Medical University trials recruiting?

Yes. 13 of its 30 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is Wroclaw Medical University testing?

Its current trials name 6 drugs and biologicals as interventions. The most frequent are Influenza vaccination (2), Ferinject (1), IPRF (1), Platelet rich plasma (1) and Platelet-Rich Fibrin (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

Wroclaw Medical University clinical trials